drugset / Trial / NCT00310856
Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months)
RandomizedParallel-groupOpen-labelPrevention
Summary
To assess the immunogenicity of Novartis (formerly Chiron) Meningococcal ACWY conjugate vaccine (MenACWY) when administered as a two-dose schedule at 6 and 12 months of age.
Timeline
- Start
- 2005-06
- Primary completion
- 2006-11
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MenACWY-CRM | Vaccine | 0.5 ml | Intramuscular |
| Subject | MenC-CRM | Vaccine | 0.5 ml | Intramuscular |
| Background | DTaP-Hib-IPV | Vaccine | — | — |
| Background | MMR | Unknown | — | — |
| Background | PC7 | Vaccine | 0.5 ml | Intramuscular |
| Background | Varicella | Vaccine | — | — |